Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2020-07-14
Buyer: NHS England and NHS Improvement South West
Country: UK
Contract type: Services
CPV classification: 85000000

Technical requirements: NHS England and NHS Improvement South West — Market Engagement — Diabetic Eye Screening Programmes for Bath and North East Somerset, Swindon and Wiltshire and Dorset
This notice is placed as a prior information notice (PIN) and relates to a pre-procurement market engagement questionnaire and event/s.
NHS England and NHS Improvement South West (the Commissioner) seeks to re-commission two diabetic eye screening programmes (DESP), one for the populations of Bath and North East Somerset (B&NES), Swindon and Wiltshire and one for the population of Dorset.
The Commissioner invites expressions of interest (EOI) from suitably qualified and experienced providers to provide the NHS DESP in line with strict national standards and guidelines to eligible patients living and registered in the identified geographies.
To register your expression of interest, please register on the eProcurement portal, InTend and submit a completed provider market engagement questionnaire.
This notice is placed as a prior information notice (PIN) and relates to a pre-procurement market engagement questionnaire and event/s.
NHS England and NHS Improvement South West (the Commissioner) seeks to re-commission a diabetic eye screening programme (DESP) to deliver screening to the eligible populations of Bath and North East Somerset (B&NES), Swindon and Wiltshire (Lot 1). This requirement is due to the current contract expiring.
The Commissioner invites expressions of interest (EOI) from suitably qualified and experienced providers to provide the NHS DESP in line with strict national standards and guidelines to eligible patients living and registered in the identified geographies.
The eligible population of includes patients over the age of 12 diagnosed with diabetes and registered with or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy.
• is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous professional development (CPD) and quality assurance (QA) schemes;
• call/recall for all people with diabetes invited for routine digital screening — this is currently undertaken on an annual basis but screening intervals are likely to extend to 2 years for people at low risk during the contract term in line with national guidance;
• slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Further information on the DESP is available at: https://www.gov.uk/topic/population-screening-programmes/diabetic-eye
The contract value has not yet been finalised. However, for indicative purposes the current annual contract value for 2020/21, based upon achieving the minimum acceptable 75 % uptake, is GBP 1 400 000.